SYSTEMIC INHIBITION OF TRANSFORMING GROWTH FACTOR-2 IN GLIOMA-BEARING MICE IMPROVES THE THERAPEUTIC EFFICACY OF GLIOMA-ASSOCIATED ANTIGEN PEPTIDE VACCINES

被引:0
|
作者
Ueda, Ryo
Fujita, Mitsugu
Zhu, Xinmei
Sasaki, Kotaro
Kastenhuber, Edward R.
Kohanbash, Gary
McDonald, Heather A.
Harper, Jay
Lonning, Scott
Okada, Hideho
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:617 / 617
页数:1
相关论文
共 3 条
  • [1] Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
    Ueda, Ryo
    Fujita, Mitsugu
    Zhu, Xinmei
    Sasaki, Kotaro
    Kastenhuber, Edward R.
    Kohanbash, Gary
    McDonald, Heather A.
    Harper, Jay
    Lonning, Scott
    Okada, Hideho
    CLINICAL CANCER RESEARCH, 2009, 15 (21) : 6551 - 6559
  • [2] SYSTEMIC INHIBITION OF TRANSFORMING GROWTH FACTOR B IN GLIOMA-BEARING MICE IMPROVED THE THERAPEUTIC EFFICACY OF PEPTIDE VACCINATIONS TARGETING GLIOMA-ASSOCIATED ANTIGENS
    Ueda, Ryo
    Fujita, Mitsugu
    Zhu, Xinmei
    Sasaki, Kotaro
    Kastenhuber, Edward R.
    Kohanbash, Gary
    McDonald, Heather A.
    Harper, Jay
    Lonning, Scott
    Okada, Hideho
    NEURO-ONCOLOGY, 2009, 11 (06) : 882 - 882
  • [3] Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice
    Zhang, Yufei
    Luo, Feifei
    Li, Anning
    Qian, Jiawen
    Yao, Zhenwei
    Feng, Xiaoyuan
    Chu, Yiwei
    CLINICAL IMMUNOLOGY, 2014, 154 (01) : 26 - 36